Development Pathways for Complex APIs and Sterile Finished Dosage Forms
Raysun is developing a focused service platform for peptide, growth hormone and oligonucleotide programs. Service availability, manufacturing location, GMP status, scale and timing are confirmed through a program-specific technical and quality review.
How We Work
Our intended service pathway connects molecule and formulation understanding with process design, analytical strategy, sterile presentation, technology transfer and lifecycle control. The precise scope for each program is defined in an approved proposal and quality agreement. The Vientiane sterile facility is under development and is not yet available for routine GMP manufacture.